Literature DB >> 28626254

The maximum standardized uptake value increment calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography predicts survival in patients with oral tongue squamous cell carcinoma.

Natsuki Yonezawa1, Tsutomu Minamikawa1, Kazuhiro Kitajima2, Yusuke Takahashi1, Ryohei Sasaki3, Ken-Ichi Nibu4, Takahide Komori1.   

Abstract

The aim of this study was to investigate the prognostic value of dual-time-point (DTP) 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging in primary oral tongue squamous cell carcinoma (OTSCC). The study included 52 patients who underwent preoperative 18F-FDG PET scans at two time points, namely 1 h and 2 h after injection. The following PET parameters were calculated: maximum standardized uptake value (SUVmax) for both time points (SUV early, SUV delayed); retention index (RI); and SUVmax increment (ΔSUVmax). Receiver operating characteristic (ROC) curve analysis was performed to define the optimal cutoff point for these parameters. Overall survival was calculated using the Kaplan-Meier method. Prognostic factors for patients with OTSCC were evaluated using the univariate log-rank test and a multivariate Cox proportional hazards model. ROC analysis revealed that the area under the curve was higher and more accurate for ΔSUVmax than for the other parameters. Additionally, patients with a ΔSUVmax ≥0.9 had significantly worse survival outcomes (28.9% vs 92.6%; p < 0.01). Univariate analysis showed that prognosis was significantly correlated with clinical T stage, local recurrence, perineural invasion, vascular invasion, and PET parameters (p < 0.05 for all). Multivariate analysis showed that local recurrence (hazard ratio = 3.60; p = 0.02) and ΔSUVmax (hazard ratio = 8.43; p < 0.01) were independent prognostic factors. ΔSUVmax determined using DTP 18F-FDG PET may be an additional prognostic factor in OTSCC patients.

Entities:  

Keywords:  Dual-time-point 18F-FDG PET; Oral tongue squamous cell carcinoma; PET parameters; Prognosis; Standardized uptake value

Mesh:

Substances:

Year:  2017        PMID: 28626254      PMCID: PMC5472544          DOI: 10.18999/nagjms.79.2.189

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  22 in total

Review 1.  Global epidemiology of oral and oropharyngeal cancer.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

2.  FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma.

Authors:  Hidenori Suzuki; Yasuhisa Hasegawa; Akihiro Terada; Ikuo Hyodo; Tsutomu Nakashima; Masami Nishio; Tsuneo Tamaki
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

3.  Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer.

Authors:  Bal Sanghera; Wai Lup Wong; Martin A Lodge; Sharon Hain; David Stott; John Lowe; Catherine Lemon; Kate Goodchild; Michele Saunders
Journal:  Nucl Med Commun       Date:  2005-10       Impact factor: 1.690

4.  Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.

Authors:  H Minn; M Lapela; P J Klemi; R Grénman; S Leskinen; P Lindholm; J Bergman; E Eronen; M Haaparanta; H Joensuu
Journal:  J Nucl Med       Date:  1997-12       Impact factor: 10.057

5.  Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma.

Authors:  Ronan Abgral; Pierre-Yves Le Roux; Jean Rousset; Solène Querellou; Gérald Valette; Emmanuel Nowak; Alexandre Turzo; Valentin Tissot; Rémi Marianowski; Pierre-Yves Salaün
Journal:  Nucl Med Commun       Date:  2013-06       Impact factor: 1.690

6.  Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose.

Authors:  Abdelkarim S Allal; Daniel O Slosman; Tayeb Kebdani; Mohamed Allaoua; Willy Lehmann; Pavel Dulguerov
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-08-01       Impact factor: 7.038

7.  The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro.

Authors:  A Waki; H Kato; R Yano; N Sadato; A Yokoyama; Y Ishii; Y Yonekura; Y Fujibayashi
Journal:  Nucl Med Biol       Date:  1998-10       Impact factor: 2.408

8.  Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity.

Authors:  In Sun Ryu; Jae Seung Kim; Jong-Lyel Roh; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-01       Impact factor: 9.236

9.  Prognostic value of 2-[(18) F]fluoro-2-deoxy-D-glucose positron emission tomography for patients with oral squamous cell carcinoma treated with retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy.

Authors:  Mai Shimizu; Kenji Mitsudo; Izumi Koike; Masataka Taguri; Toshinori Iwai; Toshiyuki Koizumi; Senri Oguri; Mitomu Kioi; Makoto Hirota; Tomio Inoue; Iwai Tohnai
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-10-24

10.  FDG-PET. A possible prognostic factor in head and neck cancer.

Authors:  W Halfpenny; S F Hain; L Biassoni; M N Maisey; J A Sherman; M McGurk
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

View more
  2 in total

1.  A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma.

Authors:  Chun-Ta Liao; Chia-Hsun Hsieh; Wen-Lang Fan; Shu-Hang Ng; Nai-Ming Cheng; Li-Yu Lee; Chuen Hsueh; Chien-Yu Lin; Kang-Hsing Fan; Hung-Ming Wang; Chih-Hung Lin; Chung-Kan Tsao; Chung-Jan Kang; Tuan-Jen Fang; Shiang-Fu Huang; Kai-Ping Chang; Li-Ang Lee; Ku-Hao Fang; Yu-Chien Wang; Lan-Yan Yang; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-06       Impact factor: 9.236

2.  Dual-time-point PET/CT study protocol can improve the larynx cancer diagnosis.

Authors:  Agata Karolina Pietrzak; Joanna Kazmierska; Andrzej Marszalek; Pawel Golusinski; Aleksandra Heydrych; Katarzyna Wiechec; Witold Cholewinski
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.